Nothing against Cramer(as he is respected in the investment community) but I personally felt that Trius deserved more than a few seconds of scrutiny.
It didn't do the company justice.
Having the CEO on his show would've cleared up a lot of uncertainties but I don't see that happening;at least until they file the NDA and he sees the overwhelming safety and efficacy data presented in type form.
I would love to see a segment containing three of the smaller biopharma CEO's (Trius included,of course) and after an ample discussion,let the viewer determine each company's viability and potential for growth.
Realizing he had time constraints,he did what he could to both entertain and educate in the time allotted.
Alas,it's his show and I wouldn't be surprised if those invested in TSRX have been tweeting him that the company deserves a more in depth analysis.
Take Care and God Bless....God Bless Us All
Res Ipsa Loquitur
Truth4Once